Recruitment has begun at three leading Cambridgeshire NHS Trusts for volunteers to take part in the nationwide COVID-19 vaccine trial.
Tags: spotlight-on-future-therapeutics future-therapeutics infectious-diseases covid-19 coronavirus
Repurposing existing medicines focused on known drug targets is likely to offer a more rapid hope of tackling COVID-19 than developing and manufacturing a vaccine, argue an international team of scientists in the British Journal of Pharmacology.
Tags: spotlight-on-future-therapeutics medicine future-therapeutics covid-19 coronavirus
The world’s first licensed, downloadable artificial pancreas app for people with type 1 diabetes launches today, based on over a decade of research by Professor Roman Hovorka at the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust.
Tags: spotlight-on-future-therapeutics future-therapeutics type-1-diabetes diabetes app
The race is on to find a vaccine against the new COVID-19 coronavirus. Professor Jonathan Heeney explains why a cautious approach is needed and how his team is using new technology developed for influenza and Ebola viruses to target the new infection.
Tags: spotlight-on-future-therapeutics future-therapeutics infectious-diseases
Proteins in our blood could in future help provide a comprehensive ‘liquid health check’, assessing our health and predicting the likelihood that we will we will develop a range of diseases, according to research published today in Nature Medicine.
Tags: spotlight-on-future-therapeutics future-therapeutics diagnostic protein proteomics
Some MRSA infections could be tackled using widely-available antibiotics, suggests new research from an international collaboration led by scientists at the University of Cambridge and the Wellcome Sanger Institute.
Tags: spotlight-on-infectious-diseases spotlight-on-future-therapeutics
Virtual reality (VR) can identify early Alzheimer’s disease more accurately than ‘gold standard’ cognitive tests currently in use, suggests new research from the University of Cambridge.
Tags: spotlight-on-neuroscience spotlight-on-future-therapeutics virtual-reality alzheimers-disease
Interplay between mitochondria and the nucleus may have implications for changing cell’s ‘batteries’
Mitochondria, the ‘batteries’ that produce our energy, interact with the cell’s nucleus in subtle ways previously unseen in humans, according to research published today in the journal Science.
Tags: spotlight-on-future-therapeutics cell mitochondria
Scientists at the University of Cambridge have developed a new test that can reliably predict the future course of inflammatory bowel disease in individuals, transforming treatments for patients and paving the way for a personalised approach.
Tags: spotlight-on-future-therapeutics spotlight-on-innovation inflammatory-bowel-disease crohns-disease ulcerative-colitis
A prescription drug to treat high blood pressure has shown promise against conditions such as Parkinson’s, Huntington’s and forms of dementia in studies carried out in mice and zebrafish at the University of Cambridge.
Tags: spotlight-on-neuroscience spotlight-on-future-therapeutics animal-research parkinsons-disease huntingtons-disease dementia
Page 1 of 2